The Inflammation Reflex (5.20.2022)

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.  This week neuroimmunology leading to therapy, the cold shoulder approach and Regulatory updates from the FDA

RNL 2022- Spondyloarthritis Spectrum

This RheumNow Live 2022 session features highlights from lectures on Spondyloarthritis. 
- Microbiome in Spondyloathritis - Jose Scher, MD
- Axial Psoriatic Arthritis - Philip Mease, MD
- Juvenile Spondyloathritis - Pamela Weiss, MD

Methotrexate Monitoring (5.13.2022)

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. Bad news for digitial ulcers in Systemic sclerosis, Readmissions in Lupus and Thrombocytopenia in APL patients.

RNL 2022 - Psoriatic Arthritis Advances

Join us for session highlights from RheumNow Live 2022. This webinar will feature highlights from these lectures followed by live audience Q & A:

Psoriatic Arthritis Guidelines
Arthur Kavanaugh, MD

Drug Targeting in PsA
Bruce Kirkham, MD
 
PsA Registries and Real World Data
Alexis Ogdie, MD

What is JAKne (5.6.2022)

Dr. Jack Cush reviews the news, journal reports, FDA actions, new side effects and changing prevalence of Gout.

Tuesday Night Rheumatology- RA - Improving Future Therapy

Join us for session highlights from RheumNow Live 2022. This webinar will feature highlights from these lectures followed by live audience Q & A:

Treatment Choices in Refractory RA - Dr. Jack Cush
Adherence to Rheumatoid Therapies - Dr. Kaleb Michaud
Precision Medicine in RA - Dr. Ernest Choy

$30 Billion and Counting (4.29.2022)

Dr. Jack Cush reviews the news and journal reports and takes viewer questions this week

QD Clinics on PsA

QD190 - PsA Sine Psoriasis  https://youtu.be/FlhAve8eaXA
QD191 - After TNF Inhibitor in PsA  https://youtu.be/yoxQPGWpkaw
QD192 - IBD or IL-17 induced Colitis?   https://studio.youtube.com/video/JQem54VwJ5c/edit

TNR- PsA Journal Club

This one-hour live Journal Club will discuss the following two articles:

Safety and efficacy of faecal microbiota transplantation in PsA. Ann Rheum Dis. 2021 Sep;80(9):1158-1167

SPIRIT H@H trial: ixekizumab versus adalimumab in biologic-naive PsA. Ann Rheum Dis. 2020 Oct;79(10):1310

Please note the updated speaker lineup:

Dr. Eric Ruderman
Dr. Arthur Kavanaugh
Dr. David Liew
Dr. Jack Cush

The Future of PsA - Part 2

- The Future of PsA Imaging - Dr. Philip Conaghan  https://www.youtube.com/watch?v=jdV4u9Jyh7c
- Prevention of PsA - Dr. Alexis Ogdie  https://www.youtube.com/watch?v=XAX5kTYx7BM
- The Future of Psoriasis Therapeutics - Dr. Kenneth Gordon  https://www.youtube.com/watch?v=RnoA94b_N_Y
- Future Biomarkers in PsA - Dr. Katy Leung   https://www.youtube.com/watch?v=y50ukfLuXlk
- Future Discovery in PsA - Dr. Christopher Ritchlin https://www.youtube.com/watch?v=qGVyo7BzU3c